PMID: 7582905Jun 1, 1995Paper

Viral peptide specific cytotoxic T lymphocytes are of high avidity to host-MHC but only low avidity to donor-MHC after allogeneic bone marrow transplantation

Transplant Immunology
D Kyburz, D E Speiser

Abstract

In the thymus maturing T lymphocytes are positively selected for efficient interaction with self-MHC molecules. Consequently, mature peripheral T cells recognize foreign (microbial) antigens in association with self-MHC molecules (known as MHC restricted recognition). In experimental bone marrow transplantation (BMT) lymphohaemopoietic stem cells from an MHC disparate donor transfused to an irradiated host give rise to mature T lymphocytes with host-MHC restriction specificity. While experiments with T cell receptor transgenic mice have largely confirmed this concept, many studies using genetically unmanipulated animals analysing polyclonal T cell repertoires have also shown donor-MHC restricted T cell activities after allogeneic BMT. To analyse this discrepancy we generated 18 virus specific cytotoxic T cell (CTL) clones, 16 from F1 into parent and two from fully allogeneic bone marrow chimeras, and analysed the MHC restriction specificity in proliferation and cytotoxicity assays. The cytotoxicity of all the clones was primarily host-MHC restricted. However, the CTL clones proliferated to viral antigen presented by both donor- or host-MHC. Our model allowed CTL cloning by cross-specific stimulation with antigen plus either don...Continue Reading

References

Aug 1, 1979·European Journal of Immunology·H von BoehmerW Haas
May 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·M J Bevan
Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·R FinbergB Benacerraf
Mar 1, 1978·The Journal of Experimental Medicine·R M ZinkernagelJ Klein
Jan 1, 1979·Immunological Reviews·J A Ledbetter, L A Herzenberg
Apr 9, 1992·The New England Journal of Medicine·D E SpeiserR M Zinkernagel
Oct 24, 1991·The New England Journal of Medicine·D H Sachs
Jun 1, 1988·The Journal of Experimental Medicine·F R CarboneM J Bevan
Jan 26, 1989·The New England Journal of Medicine·C AnasettiE Mickelson
Jan 1, 1988·Immunological Reviews·J SprentY Ron
Sep 26, 1985·The New England Journal of Medicine·P G BeattyR Storb
Nov 24, 1971·Nature: New Biology·I R Pedersen
Jan 1, 1981·Immunogenetics·C J MeliefR W Melvold
Mar 31, 1994·Nature·P Marrack, D C Parker

❮ Previous
Next ❯

Citations

Mar 1, 1996·Molecular Medicine Today·G E Sale
Aug 1, 1997·Journal of Virology·M F BachmannP S Ohashi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.